Home / Import refusals / SCS-7250416-2/11/1

FDA Import Refusal SCS-7250416-2/11/1 — Merck Sharp & Dohme LLC

Merck Sharp & Dohme LLC — FEI 1036761

The FDA refused shipment SCS-7250416-2/11/1 from Merck Sharp & Dohme LLC (United States) on September 17, 2021. The refused product falls under Drugs and Biologics — LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
September 17, 2021
Country
United States
Product Category
Drugs and Biologics
Product Code
62ODY41 LOSARTAN POTASSIUM (ANTI-HYPERTENSIVE - PART II)
Charges
75

Recent inspections

  • 1225396 (NAI Thu Nov 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1089774 (NAI Fri Apr 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1056085 (NAI Thu May 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 961626 (NAI Thu Jan 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 839393 (NAI Fri Jun 28 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-4002958-7/11/1 (Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-2877444-4/11/1 (Wed Mar 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-2134762-0/11/1 (Fri Apr 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-2134762-0/11/2 (Fri Apr 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-0601435-1/11/1 (Tue Feb 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources